Fasvivo Injection - Fulvestrant 50mg/mL

Fas vivo injection is a prescription medication containing fulvestrant 50mg/mL, a potent drug used in the treatment of hormone-receptor positive (HR+) metastatic breast cancer. It acts by blocking estrogen receptors, thereby inhibiting the growth and spread of tumor cells.

Mechanism of Action: Fasvivo Injection directly targets estrogen within the body's cells, preventing them from accessing and responding to the hormone's signal for cell proliferation. This process ultimately slows down the progression of HR+ metastatic breast cancer.

Indications: Fas vivo injection is prescribed for women with advanced or metastatic breast cancer who have previously received chemotherapy for their disease. It is an essential treatment option when hormonal therapies are needed.

Key Features:
* High-concentration formulation: Provides a potent therapeutic dose of fulvestrant in a convenient single injection.
* Ease of administration: Delivered via a simple, intramuscular injection.

This medication should only be used under the guidance of your healthcare provider following appropriate diagnosis and consultation. Consult your doctor for details on dosage and administration instructions.

Note: This information is intended for general knowledge and does not constitute medical advice. Always consult your physician regarding your specific medical condition.